News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
867,579 Results
Type
Article (87800)
Company Profile (824)
Press Release (778938)
Multimedia
Podcasts (188)
Webinars (28)
Section
Business (233184)
Career Advice (4144)
Deals (39844)
Drug Delivery (144)
Drug Development (91373)
Employer Resources (203)
FDA (18365)
Job Trends (17415)
News (397750)
Policy (39953)
Tag
Academia (3006)
Academic (2)
Accelerated approval (30)
Adcomms (35)
Allergies (136)
Alliances (56981)
ALS (174)
Alzheimer's disease (1765)
Antibody-drug conjugate (ADC) (315)
Approvals (18513)
Artificial intelligence (583)
Autoimmune disease (140)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (195)
Biotechnology (488)
Bladder cancer (154)
Brain cancer (62)
Breast cancer (632)
Cancer (4771)
Cardiovascular disease (416)
Career advice (3566)
Career pathing (40)
CAR-T (294)
CDC (59)
Celiac Disease (1)
Cell therapy (794)
Cervical cancer (37)
Clinical research (76668)
Collaboration (1631)
Company closure (5)
Compensation (1089)
Complete response letters (65)
COVID-19 (2983)
CRISPR (94)
C-suite (753)
Cystic fibrosis (148)
Data (5937)
Decentralized trials (2)
Denatured (69)
Depression (133)
Diabetes (502)
Diagnostics (7180)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (279)
Drug pricing (208)
Drug shortages (36)
Duchenne muscular dystrophy (227)
Earnings (99909)
Editorial (60)
Employer branding (25)
Employer resources (173)
Events (134603)
Executive appointments (1011)
FDA (21307)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1455)
Gene editing (205)
Generative AI (60)
Gene therapy (635)
GLP-1 (1093)
Government (5429)
Grass and pollen (8)
Guidances (380)
Healthcare (20941)
HIV (56)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (278)
Immuno-oncology (44)
Indications (79)
Infectious disease (3258)
Inflammatory bowel disease (199)
Inflation Reduction Act (16)
Influenza (115)
Intellectual property (224)
Interviews (816)
IPO (17946)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (653)
Leadership (39)
Legal (10155)
Liver cancer (95)
Longevity (14)
Lung cancer (655)
Lymphoma (367)
Machine learning (40)
Management (66)
Manufacturing (766)
MASH (168)
Medical device (14978)
Medtech (15019)
Mergers & acquisitions (22897)
Metabolic disorders (1312)
Multiple sclerosis (152)
NASH (23)
Neurodegenerative disease (327)
Neuropsychiatric disorders (87)
Neuroscience (2987)
NextGen: Class of 2025 (7703)
Non-profit (5103)
Now hiring (62)
Obesity (629)
Opinion (327)
Ovarian cancer (156)
Pain (194)
Pancreatic cancer (210)
Parkinson's disease (278)
Partnered (36)
Patents (475)
Patient recruitment (428)
Peanut (59)
People (66674)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23678)
Phase II (33265)
Phase III (25088)
Pipeline (4091)
Policy (323)
Postmarket research (3554)
Preclinical (10671)
Press Release (72)
Prostate cancer (233)
Psychedelics (53)
Radiopharmaceuticals (292)
Rare diseases (825)
Real estate (7437)
Recruiting (80)
Regulatory (28670)
Reports (65)
Research institute (2719)
Resumes & cover letters (651)
Rett syndrome (24)
RNA editing (16)
RSV (82)
Schizophrenia (152)
Series A (244)
Series B (179)
Service/supplier (30)
Sickle cell disease (101)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (47)
Startups (4327)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (97)
The Weekly (117)
Vaccines (1114)
Venture capital (82)
Weight loss (440)
Women's health (79)
Worklife (21)
Date
Today (66)
Last 7 days (453)
Last 30 days (2444)
Last 365 days (33231)
2025 (33118)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (86)
Alaska (7)
Arizona (328)
Arkansas (14)
Asia (51381)
Australia (9025)
California (10927)
Canada (3193)
China (1079)
Colorado (460)
Connecticut (484)
Delaware (330)
Europe (118069)
Florida (1599)
Georgia (354)
Hawaii (3)
Idaho (68)
Illinois (905)
India (62)
Indiana (527)
Iowa (22)
Japan (398)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1402)
Massachusetts (8093)
Michigan (344)
Minnesota (636)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (81)
New Jersey (2978)
New Mexico (32)
New York (2918)
North Carolina (1544)
North Dakota (10)
Northern California (5162)
Ohio (332)
Oklahoma (22)
Oregon (52)
Pennsylvania (2213)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (61)
South Dakota (1)
Southern California (4199)
Tennessee (169)
Texas (1725)
United States (39732)
Utah (327)
Vermont (1)
Virginia (275)
Washington D.C. (85)
Washington State (922)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
There are 867,579 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
December 24, 2025
·
13 min read
Press Releases
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
December 24, 2025
·
11 min read
Press Releases
WuXi Biologics Recognized by Hong Kong ESG Reporting Awards 2025 for Outstanding ESG Disclosure
December 24, 2025
·
3 min read
Press Releases
Nona Biosciences Expands Integrated Discovery-to-Clinical Capabilities Through Strategic Platform Growth
December 24, 2025
·
3 min read
Press Releases
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
December 24, 2025
·
15 min read
Press Releases
Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study
December 24, 2025
·
5 min read
Press Releases
SN BioScience received US FDA Orphan Drug Designation for its Nano Anti-Cancer Drug ‘SNB-101' on Gastric Cancer.
December 24, 2025
·
3 min read
Press Releases
LSL PHARMA GROUP ANNOUNCES CLOSING OF THE ACQUISITION OF JUNO OTC AND FINAL $2M CLOSING OF UPSIZED $12M OFFERING
December 24, 2025
·
6 min read
Press Releases
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
December 24, 2025
·
4 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
December 24, 2025
·
11 min read
1 of 86,758
Next
